Get the Stockscreener App
2.10
4.98%
-0.11
After Hours:
2.07
-0.03
-1.43%
Ispecimen Inc stock is traded at $2.10, with a volume of 53,777.
It is down -4.98% in the last 24 hours and down -17.65% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$2.21
Open:
$2.22
24h Volume:
53,777
Relative Volume:
0.09
Market Cap:
$3.02M
Revenue:
$1.03M
Net Income/Loss:
$-11.10M
P/E Ratio:
-0.0318
EPS:
-66.0832
Net Cash Flow:
$-8.21M
1W Performance:
-16.00%
1M Performance:
-17.65%
6M Performance:
-86.23%
1Y Performance:
-94.90%
1-Day Range:
$2.0612
$2.22
1-Week Range:
$2.0612
$2.49
52-Week Range:
$2.0612
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
2.10 | 3.18M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen (ISPC) Registration filing Summary - Quartr
iSpecimen (NASDAQ: ISPC) targets $5M best‑efforts equity raise - Stock Titan
iSpecimen Inc (NASDAQ: ISPC) Share Price, ISPC Stock News, ISPC Share Price & Updates - Kalkine
iSpecimen advances digital transformation with Milestone 3 completion - TipRanks
ISPC Q3 2024 Earnings: Wider-Than-Expected Loss Sparks Surprising Stock SurgeDividend Increase Stocks - dars.gov.et
ISPC Q3 2024 Earnings: Wider-than-Expected Loss Yet Shares SurgeSpecial Dividend Alert - DonanımHaber
iSpecimen (NASDAQ: ISPC) files S-1/A for up to $4M equity and pre-funded warrants - Stock Titan
ISPC Q3 2024 Earnings: EPS Misses Estimates by a Wide Margin, Stock DeclinesAdjusted Earnings Analysis - dars.gov.et
iSpecimen Inc. (ISPC) Q3 2024 Earnings: EPS Misses Estimates by Wide Margin as Revenue Remains UnreportedOne-Time Gain Impact - dars.gov.et
ISPC Q3 2024 Earnings: Massive EPS Miss and Operational Challenges PersistEBITDA Estimate Trend - DonanımHaber
ISPC Q3 2024 Earnings: Significant EPS Miss Amid Operational ChallengesProfit Warning Alert - dars.gov.et
ISPC Q3 2024 Earnings: EPS Misses Steeply as Revenue Remains Unreported, Stock Rises 3%Dividend Increase Stocks - dars.gov.et
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Staggering EPS Miss Amid Limited Revenue VisibilityGuidance Update - dars.gov.et
iSpecimen Company Profile & Introduction - Moomoo
Price to sales forward of iSpecimen Inc. – NASDAQ:ISPC - TradingView
Price to book forward of iSpecimen Inc. – NASDAQ:ISPC - TradingView
Enterprise value to EBIT forward of iSpecimen Inc. – NASDAQ:ISPC - TradingView
Price to earnings forward of iSpecimen Inc. – NASDAQ:ISPC - TradingView
ISPC Q3 2024 Earnings: Substantial EPS Miss Reflects Operational HeadwindsForward Guidance Trends - dars.gov.et
iSpecimen (ISPC) Slips 4% as Stock Tests Key Support Near $2.44Revenue Growth Stocks - dars.gov.et
iSpecimen Inc Actuals & Estimates (NASDAQ:ISPC) - TradingView
iSpecimen (ISPC) Q3 2024 Earnings: Heavy Losses but Stock Climbs 5.5%Share Dilution Risk - dars.gov.et
ISpecimen Offering Up to 1.54M Shrs - Moomoo
iSpecimen (NASDAQ: ISPC) plans $4M common stock and pre-funded warrant sale - Stock Titan
iSpecimen Inc (ISPC) Institutional Confidence - TradingKey
ISPC Q3 2024 Earnings: Significant Earnings Miss Amid Limited Revenue DisclosureEarnings Call Highlights - dars.gov.et
iSpecimen Inc. (ISPC) Gains Ground: Testing Key Resistance at $2.72Catalyst Driven Stocks - DonanımHaber
iSpecimen Stockweekly review and sector backdrop - AD HOC NEWS
ISPC Should I Buy - Intellectia AI
iSpecimen | 8-K: Current report - Moomoo
iSpecimen Inc (ISPC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
iSpecimen Inc (ISPC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
iSpecimen Inc (ISPC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
iSpecimen Inc (ISPC) Valuation: PE, PB & Fair Value Analysis - TradingKey
[EFFECT] iSpecimen Inc. SEC Filing - Stock Titan
iSpecimen Inc (ISPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
iSpecimen Inc (ISPC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iSpecimen Inc (ISPC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
iSpecimen Receives Nasdaq Noncompliance Notice, Listing at Risk - TipRanks
iSpecimen Q3 2024 Earnings: Significant EPS Miss Amidst Limited Financial DisclosureEarnings Miss Streak - newsline.com
iSpecimen Inc Stock (US46536T1016): shares in focus after quiet session - AD HOC NEWS
ISPC Q3 2024 Earnings: Massive EPS Miss with 983.59% Negative SurpriseGross Profit Margin - dars.gov.et
ISPC Q3 2024 Earnings: Widely Missed EPS Expectations, Stock Rises 6%Earnings Call Q&A - newsline.com
iSpecimen (NASDAQ: ISPC) registers 488,290 shares from May 2026 placement - Stock Titan
MSN Money - MSN
$iSpecimen (ISPC.US)$ so far so good - Moomoo
iSpecimen Inc. Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Emerging Growth Status (May 29, 2026) - Minichart
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (NASDAQ: ISPC) falls below Nasdaq equity listing requirement - Stock Titan
iSpecimen Inc. Files Form 8-K Announcing Approval of 2025 Stock Incentive Plan and Key Company Details - Minichart
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):